SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " treat " 2,744 found 🔀 AI-powered Shuffle
Treating newborns with opioid withdrawal
Giving opioid withdrawal medications based on an infant’s symptoms rather than a set schedule can shorten hospital stays.
Lung Cancer Research Foundation Grants Team Science Award Focused on Understanding and Treating Lung Cancers with HER2 Mutations
/PRNewswire/ -- The Lung Cancer Research Foundation (LCRF) announces the first recipients of its LCRF | Boehringer Ingelheim Team Science Award on Innovative...
Scientists reversed biological age in older adults with a 4-week diet change
A four-week diet change was enough to make some older adults appear biologically younger in a new University of Sydney study. Participants who reduced fat intake or shifted toward more plant-based protein showed improvements in key health biomarkers tied to aging. The strongest results came from a lower-fat, higher-carb diet, while people eating closer to their usual diets saw almost no change.
Shortage of beds, staff force Michigan kids out of state for mental health treatment
Michigan kids with serious mental health needs are being sent thousands of miles away from their families to receive proper treatment.
Ketamine therapy could be future of mental health treatment
Ketamine, a common anesthetic, is being used in Maryland to help people with major depression.
New community mental health center planned for Montpelier
Washington County Mental Health Services plans to consolidate services, offering crisis care, intensive treatment and outpatient therapy.
New coronary IVL tech from Boston Scientific impresses in first-in-human study
The company's Seismiq platform has already gained FDA approval for treating PAD. This new analysis highlights its potential to treat calcified coronary lesions during PCI procedures.
Health Officials Say "Country is Prepared" to Deal with Hantavirus
Centers for Medicare and Medicaid Services Administrator Dr. Oz tells reporters in the Oval Office that the country is prepared to deal with the Hantavirus outbreak and treat the disease, despite cuts to federal agencies. HHS Secretary Robert F. Kennedy also says the CDC has been on it from day one and has been in contact with officials in Nebraska dealing with people exposed to the virus. "We have this under control, and we're not worried about it," Kennedy says. The secretary also disputes that it took four days after the World Health Organization issued an alert for the U.S. to follow suit. "It's just not true," he says.
Hantavirus cruise ship: Breaking down health officials' update after Americans return to U.S.
Health officials provided an update from Omaha, Nebraska, after most of the American passengers aboard the hantavirus-stricken cruise ship Hondius arrived there for medical treatment. NBC News medical contributor Dr. Kavita Patel breaks down the key takeaways from the media briefing, including how the patients are being cared for and level of risk to the general population.
The skincare guru Hollywood stars trust for red-carpet skin
High-tech machines and $900 treatments: How Keren Bartov built a skincare empire and global celebrity following.
They sent their teens away for treatment. Then, everything unraveled.
After two suicides led to the sudden closure of Asheville Academy, families who had spent thousands were left scrambling to help their kids in crisis.
New AI tool developed by Stowers Institute and Helmholtz Munich scientists predicts how cells choose their future — helping uncover hidden drivers of development
Scientists at the Stowers Institute for Medical Research and Helmholtz Munich have developed RegVelo, a new AI framework that predicts how cells acquire their identities and identifies the genetic regulators guiding those changes. Published in Cell, the study used zebrafish neural crest development to show RegVelo can uncover early drivers of cell fate, including regulators of pigment cell formation, and then support those predictions experimentally. The researchers also applied the framework across multiple biological systems, suggesting its value extends beyond neural crest cells as a broadly useful tool for studying how cells change over time. The team says the new model could pave the way for future cell therapy treatments.
Learner spotlight: Vivian’s path to rights based mental health advocacy
For Vivian Anyango Aola, mental health is deeply personal. Growing up she witnessed people around her struggling with emotional distress without access to support, understanding or solutions. Those early experiences laid the foundations for her work today as a mental health advocate at St. Daniel Comboni mission in Nairobi, Kenya.“Mental health is about feelings – something we all experience every day,” Vivian explains. “Ensuring people are supported in those feelings is what drives my work.” Creating safe spaces and challenging stigmaIn her role, Vivian works closely with people living with mental health conditions and psychosocial, intellectual and cognitive disabilities. Through dialogue, listening and shared learning, she helps create safe spaces where people feel seen, heard and respected. However, stigma and discrimination remain significant barriers.“Witnessing stigma only strengthens my resolve to fight for inclusion, acceptance and equal treatment for all,” she says. Vivian enrolled in the WHO ‘QualityRights in Mental Health’ online, self-paced course available on the WHO Academy learning platform to strengthen her knowledge and advocacy skills. The six-module course provides the foundation for challenging stigma and discrimination and for promoting person-centred, rights-based approaches in mental health.“The course gave me a new perspective,” she says. “It showed me how to support people in ways that respect autonomy and promote recovery, rather than focusing only on treatment.”The importance of language and cultureSince its launch, more than 141 000 people have enrolled in the course globally, and it is now available in 17 languages on the learning platform – the highest number of languages of any WHO course. For Vivian, accessibility is key to transforming mental health systems. “Language is a bridge between professionals and communities,” she explains. “When mental health resources are available in local languages, they reduce misunderstanding, build trust and encourage people to seek help. It also empowers health workers to deliver care in ways that are culturally sensitive and relevant.”In a global evaluation of the course, which analysed data from over 3000 learners, attitudes toward people with mental health conditions improved by 22.78% overall after completing the course, with even greater shifts in low- and middle-income countries (29.18%) compared to high-income countries (20.58%)[1].“The course equips participants with the essential knowledge and skills to transform mental health into a more rights-based, inclusive and recovery-oriented system,” explains Vivian. “It reinforces that change is possible. When people understand rights, dignity and recovery, the entire system can begin to shift.”Mental Health, Brain Health and Substance Use[1] Breaking stigma, discrimination and promoting rights: global evaluation of the World Health Organization QualityRights e-training on mental health, recovery and community inclusion
American passengers from hantavirus-hit cruise ship arrive back in the U.S.
One passenger who is suffering mild symptoms will be taken to a second site to be treated separately, officials said.
Greater weight loss from GLP-1 drugs lowers health complication risk
New research to be presented at this year's European Congress on Obesity (ECO 2026, Istanbul, Turkey, 12-15 May) shows that, following treatment for obesity or diabetes or both using incretin-based drugs, losing more weight versus less weight, and losing a little weight versus gaining weight, both lead to relatively lower risk of obesity-related conditions.
How jellyfish bycatch could be valuable collagen source for cosmetics and biotech
Dr Ainara Ballesteros is a Juan de la Cierva postdoctoral researcher at the Institute of Environment and Marine Science Research at the Catholic University of Valencia, where she leads a research group focused on jellyfish biology, aquaculture, and the sustainable use of marine resources. Her work is centered on developing innovative solutions based on marine science, particularly through the study of underused organisms as sources of high-value compounds within circular bioeconomy and zero-waste strategies. She is joined in this work by Raquel Torres, a PhD student at the same institute, who is carrying out her doctoral thesis within this line of research, focused on jellyfish valorization, collaboration with the fishing sector, and the sustainable management of marine resources. They are co-authors on a new Frontiers in Marine Science article which investigated whether jellyfish accidentally caught by small-scale fishers in Spain could be transformed into a valuable resource instead of being treated as waste. The team worked side by side with fishers to better understand their perceptions of jellyfish bycatch, identify which species are most frequently caught, and evaluate whether one of them, Rhizostoma pulmo, could serve as a sustainable source of high-quality collagen.
Science spotlight: AI 'transformative' for cosmetic dermatology
Artificial intelligence (AI) offers significant promise in cosmetic dermatology, but technologies must be used in synergy with human expertise to overcome risks associated with scaled integration. According to a review published in Actas Dermo-Sifiliográficas [1], AI tools have revolutionised skin assessment and the development of personalised treatments in cosmetic dermatology already. And, looking ahead, the researchers said advances are set to further transform the category. “AI has...
Iran releases Nobel Peace Prize winner Narges Mohammadi over health concerns
On Sunday, Mohammadi, winner of the 2023 Nobel Peace Prize, was released on bail and sent to Tehran for medical treatment after 10 days of hospitalization in Zanjan, northern Iran, where she had been serving her sentence.
Iran releases Nobel laureate Narges Mohammadi on bail amid health fears
Iranian Nobel Peace Prize winner Narges Mohammadi has been released on bail and transferred to Tehran for urgent medical treatment after supporters warned she was at risk of dying in prison. The activist,…
FDA Policies: Rigorous Science or Roadblocks?
Readers debate how the Food and Drug Administration should handle treatments for rare diseases.
California must stop treating fraud as the cost of doing business
Orange County learned what happens when oversight is weakened.
How a pill approved 25 years ago transformed cancer treatment
When the Food and Drug Administration approved Gleevec to treat a form of leukemia in 2001, it ushered in a new era in cancer care.
Colorado’s rulers save democracy from the voters
Another week, another column about Colorado’s ruling class treating democracy like a state trooper treats the speed limit. It’s for other people. I swear, I want to write about literally anything else — aliens, sports, lab-grown meat, Bigfoot opening a vape shop in Pueblo. But Colorado’s legislature has never been more abusive to the citizenry […]
Turning passion into business: Tennessee community rallies behind a 15-year-old baker
Teenager Grace Nirmaier turned a hobby into Baked by Grace, a thriving bakery in Maynardville, Tennessee, inspiring locals with her ambition and sweet treats.
'Full House' star Dave Coulier shares health update amid cancer battle
Dave Coulier revealed he lost 45 pounds and struggled to eat or speak after extensive radiation treatment, while sharing positive news about his cancer prognosis.
'Full House' star Dave Coulier shares health update amid cancer battle
Dave Coulier revealed he lost 45 pounds and struggled to eat or speak after extensive radiation treatment, while sharing positive news about his cancer prognosis.
'Full House' star Dave Coulier shares health update amid cancer battle
Dave Coulier revealed he lost 45 pounds and struggled to eat or speak after extensive radiation treatment, while sharing positive news about his cancer prognosis.
'Full House' star Dave Coulier shares health update amid cancer battle
Dave Coulier revealed he lost 45 pounds and struggled to eat or speak after extensive radiation treatment, while sharing positive news about his cancer prognosis.
'Full House' star Dave Coulier shares health update amid cancer battle
Dave Coulier revealed he lost 45 pounds and struggled to eat or speak after extensive radiation treatment, while sharing positive news about his cancer prognosis.
'Full House' star Dave Coulier shares health update amid cancer battle
Dave Coulier revealed he lost 45 pounds and struggled to eat or speak after extensive radiation treatment, while sharing positive news about his cancer prognosis.
New Subnautica 2 gameplay teaser has just dropped and if you weren't excited before, you will be now
We're just days away from returning to the beautiful briny in Subnautica 2, and to celebrate, we've been treated to an …
Scientists reversed liver aging with young gut bacteria in stunning study
Rebooting the gut microbiome with bacteria from youth may help stop aging-related liver damage and even prevent liver cancer, according to new research in mice. Older mice that received their own preserved youthful microbiome showed less inflammation, reduced DNA damage, and no signs of liver cancer. Researchers also found that the treatment suppressed a cancer-linked gene called MDM2, making older mice biologically resemble younger ones.
Black licorice compound shows promise against inflammatory bowel disease
Researchers have developed a stem cell-based model of the human intestine that may transform how new IBD treatments are discovered. After testing thousands of compounds, they identified glycyrrhizin — a natural substance found in black licorice — as a promising anti-inflammatory candidate. In both lab-grown tissue and mice, the compound reduced intestinal damage and cell death linked to IBD.
Poor sleep can cause or worsen mental illness. Which treatments work and what's just hype?
Sleep disorders can cause serious physical and mental health problems. Treatments are aplenty, from gummies, lotions and meditation to apps, sounds, C-PAPs and medications. There are so many medical, over the counter, and influencer-peddled ways to treat sleep problems. What’s hype? What works? And what’s it like when it seems all the remedies are failing?
Scientists found the “holy grail” gene that could one day help humans regrow limbs
Scientists studying axolotls, zebrafish, and mice have uncovered a shared set of genes that may one day help humans regrow lost limbs. By identifying powerful “SP genes” involved in regeneration, researchers discovered that disabling these genes stopped proper bone regrowth in salamanders and mice. They then used a gene therapy inspired by zebrafish biology to partially restore regeneration in mice, marking a major step toward future treatments that could replace damaged limbs with living tissue instead of prosthetics.
Evictions, AI, public transportation bills: CT politics news
Plus: The fate of bills concerning data centers, health care affordability, fertility treatment, Aquarion Water Company and balloons.
FDA announces more recalls due to risk of syringe breaking during treatment
Medline already had to recall millions of syringes due to a significant safety risk. Now, multiple procedure kits that include the devices are also being recalled. The issue has been associated with four serious injuries.
‘It’s Yelling, Be Honest’ — How This Couple Divorced, But Still Grew Their Business to 16 Locations and $1.4 Million In Revenue
They treat their business as a “third child” that they are both committed to.
Metabolic liver disease to hit 1.8bn by 2050, and other health stories
Top health news: Metabolic liver disease is on the rise; Global pandemic treaty deadline missed again; Hantavirus cases linked to cruise ship.
The shaky policy foundations of California’s overambitious science bond
“Research is best treated as a public good — supported through sustained public investment, not borrowing tied to uncertain returns.”
PSMA PET imaging’s proliferation produces uptick in aggressive treatment for prostate cancer
First approved by the FDA in 2021, providers have rapidly adopted this clinical innovation, which offers greater accuracy in detecting prostate cancer.
Can blockbuster GLP-1 weight-loss drugs also protect brain health?
UCSF experts share their research on medications’ potential to slow or reduce risk of dementia and to treat the triggers that drive addiction.
Pyxis Oncology Appoints Nelson Azoulay as Chief Business Officer
BOSTON, May 07, 2026 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced the appointment of Nelson Azoulay as Chief Business Officer. Mr. Azoulay joins Pyxis Oncology with more than 15 years of experience in corporate strategy, business development, and value-creating transactions across the biopharma industry, including deep antibody-drug conjugate (ADC) experience. In his role,
While many international brands retreat, McDonald’s is supersizing its China business
McDonald's plans to have 10,000 locations in China by the end of 2028, and the country is its second largest market.
Delcath Systems Reports First Quarter 2026 Results and Business Highlights
QUEENSBURY, N.Y., May 07, 2026--Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced financial results and business highlights for the first quarter ended March 31, 2026.
If you want to reduce jail overcrowding, start on mental health before the crime happens
Montana keeps investing in mental health facilities for people who have broken the law, in part because of mental illness. Columnist and county attorney Matt Jennings says there's a cheaper, better way to focus on treatment and prevention.
Thongs, Taco Bell and the neuroscience of baseball’s weirdest rituals
Sports psychologists once treated rituals as a confidence trick — a placebo. The science has gotten more interesting than that.
What we’ve learned in Bristol about reproductive freedom
Abortion bans not only create barriers to health care, like we saw with the closure of the Bristol health clinic, but they also change how doctors and nurses approach treatment, guest columnist Cheryl Hanzik writes.
Former Southwest Philly refinery site will become home to nuclear life science facility
The company plans to manufacture a rare, radioactive isotope for use in cancer treatment trials starting in 2029.
Study shows risks for mental health workers in residential treatment facilities
A study published eight years ago found that each year, on average, one mental health worker is a victim of homicide in residential treatment facilities.
Science: A novel gene-therapy approach to ‘functionally cure’ HIV succeeds in some monkeys
Six animals suppressed AIDS virus after one shot of treatment that makes cell-receptor antibody
In Retreat, Health System Drops Plans to Outsource Eugene Emergency Departments to Out-Of-State Firm
Lawmakers, providers hail victory for Oregon’s newly-bolstered law limiting corporate control of medical practices.
Red-light therapy does have health benefits but not the ones you think
Red-light therapy promises to treat everything from acne and hair loss to depression and chronic pain. Many of these claims are overhyped, but evidence suggests it can have healing powers
Cancer treatments can take a toll on body image
The end of cancer treatment doesn't mean the challenges end. Sanford Health helps survivors navigate self-esteem and other concerns.
A Landslide in Alaska Set Off a Tsunami. There May Be More to Come.
Scientists say as glaciers retreat in a warming climate, landslide-generated tsunamis are likely to become more frequent.
A 1,500-foot tsunami took scientists by surprise. Now we know why it happened
By chance a tour boat avoided a deadly tsunami set off by the retreat of Alaska's coast glaciers. Scientists are working to spot landslides like the one that caused the massive to warn people in harm's way
Busting five myths about mental health with University of Minnesota experts
University of Minnesota experts are setting the record straight with evidence-based research, new treatments and workforce innovations that are changing how mental health conditions are understood and treated.
Wisconsin lab tapped to research psychedelic drug as mental health treatment
A Wisconsin-based medical research lab is one of just three organizations nationwide the federal government has tapped to move forward on research into psychedelic medications.
How science is taking tripping mainstream
President Trump recently signed an order to speed up the evaluation of psychedelics to treat the brain. That’s coming after decades of strict prohibition on psychedelic drug use dating back to President Nixon. So how did we go from that to a psychedelic renaissance? A look into a key institution in the world of psychedelic research may give us some clues. This episode, NPR’s brain correspondent Jon Hamilton shares insight from a recent trip. (No pun intended.) Want more psychedelic content? Catch our episode on ketamine therapy here, or learn why some scientists want to take the trip out of psychedelics here. Have other questions about psychedelics and the brain? Let us know by emailing shortwave@npr.org!
Oil prices retreat and global stocks hit record highs after Trump hails ‘great progress’ on Iran deal
US president pauses ‘Project Freedom’ to work on ‘final agreement’ with Tehran; stocks also ride high on AI euphoria
Impella 5.5 shows promise in certain non-shock, high-risk cardiac surgery patients
New data out of the AATS Annual Meeting identified significant potential for a new treatment strategy.
Mental Health Awareness Month highlights rising needs across western North Carolina
May is Mental Health Awareness Month. Nearly 30 million people across the U.S lack access to affordable, comprehensive mental health and substance treatment.
A better path forward for cancer care - UT Health San Antonio
From the moment of diagnosis, UT Health San Antonio patients are connected to a system designed to expand their treatment possibilities and bring the full strength of medicine and research to their care. Specialized programs focus on common and rare cancers, which allows for more personalized treatment approaches. For those at increased risk, services such as cancer genetics counseling and risk-reduction clinics offer early insight and prevention strategies.
Woman in cancer remission without treatment in highly unusual case
A biopsy of a woman's cancer seems to have triggered an immune response against the tumour, putting her into remission
Dolly Parton cancels Las Vegas residency and gives health update
“The good news is I’m responding really well to meds and treatments and I’m improving every day,” the 80-year-old star said.
Country music legend cancels concerts, admits feeling ‘swimmy headed’
The Rock and Roll Hall of Famer said she's responding well to medicine and treatment.
Dolly Parton cancels Las Vegas residency due to health issues: ‘Everything I have is treatable’
Country superstar assures fans her health issues are treatable
Dolly Parton cancels Las Vegas residency due to health issues: 'Everything I have is treatable'
Dolly Parton has canceled her previously postponed Las Vegas residency due to health challenges.
Dolly Parton cancels Las Vegas residency and steps back from performing amid health concerns
Dolly Parton did not disclose the specific health condition that she is receiving treatment for, but said that she would be too dizzy to take the stage for her residency this year.
Dolly Parton cancels Las Vegas residency over health issues: ‘I’ve still got some healing to do’
The 80-year-old singer will not be performing rescheduled dates in September but assured fans she is receiving treatment and ‘improving every day’
Dolly Parton cancels Las Vegas residency as health issues force her to step back from stage performances
Dolly Parton cancels Las Vegas residency due to ongoing health issues but says she is improving every day and her conditions are all treatable.
Dolly Parton Cancels Las Vegas Residency Due to Health, Shares Update
"I'm responding really well to meds and treatments, and I'm improving everyday," the Grammy winner said, while noting that "it's gonna take me a little while before I'm up to stage-performance level."
Dolly Parton gives health update: ‘Good news and a little bad news’
KNOXVILLE, Tenn. (WATE) — Dolly Parton gave a health update Monday afternoon sharing “good news and a little bad news.” Parton said she was responding well to medicine and treatments an…
Baptist hospital
PENSACOLA, Fla. -- When a patient’s heart and lungs are too weak to function, a specialized rescue treatment called ECMO can provide short- to long-term support
COA and Flatiron Health Study Finds Patients May Experience Longer Survival in Community Oncology Settings
Patients diagnosed with metastatic breast cancer and non–small cell lung cancer had longer survival compared to national benchmarks when treated in independent community oncology practices, according ...
Trump Backed Forced Treatment for Homeless People. Utah Shows the Challenges.
State lawmakers declined to back a Trump-inspired plan to move 1,300 homeless people to a campus on the edge of Salt Lake City, but supporters are trying to keep the plan’s spirit alive.
How Republicans came to embrace psychedelic drugs
After decades of backing a “war on drugs,” the GOP has warmed to psychedelics for mental health treatment as high-profile backers and veterans tout the drugs.
Global Health & WASH: May 2026 Funding Opportunities (14 new opportunities!)
The May update for Global Health & WASH brings new calls that cluster around three distinct shifts: LMIC research leadership moving from funder encouragement into a hard eligibility constraint, pharmaceutical and corporate-linked funders running structurally independent education and use-inspired research portfolios at substantial scale, and AI adoption shifting decisively from speculative tool to operational capability across health and WASH systems alike. In LMIC Research Leadership as Eligibility, Not Encouragement, Wellcome anchors the dominant signal of the month with three separate major calls that all require or strongly center LMIC leadership in their basic eligibility architecture. Wellcome’s ESIC Hubs (£1.5-£1.9M per hub over 3-5 years) explicitly requires an LMIC-based lead applicant, treating Global South leadership as a design constraint rather than a participation goal. Wellcome’s Infectious Disease Clinical Trial Development Award funds transdisciplinary teams whose lead must be a mid-career or established researcher based at an organization in Africa, South Asia, or Southeast Asia. Wellcome’s larger Infectious Disease Clinical Trial Award (£1M-£8M for optimizing licensed interventions) requires the administering organization to be in eligible LMIC regions and at least 50% of applicants based there. Around Wellcome, the same pattern shows up at smaller scale and across funders: CHINNOVA channels $1M into West and Central African research institutions for climate-health work; IBRO’s Neuroscience Training Grants explicitly tier ceilings by region of residence with Africa receiving the highest amount ($5,000); IHME’s GBD Emerging Researcher Award reserves at least one of its two annual awards for an LMIC researcher; Sidaction’s HIV Cure call funds research teams across France, the Netherlands, and eligible African countries with a minimum two-country collaboration requirement. Taken together, these calls signal a meaningful shift in how research equity is being operationalized — not as encouragement language at the bottom of a call, but as a structural feature of who can lead, where the work must be administered, and what proportion of the team must be regionally rooted. In Pharma-Funded Independent Medical Education and Use-Inspired Research, the lineup this month is unusually deep. Pfizer alone runs four parallel calls under independent education and quality improvement frameworks: a Migraine and Women’s Health RFP (200K x 2-year, $500K pool), Migraine IME ($200K, $1M pool), JAK Inhibitor evidence-based education ($100K), and Maternal Vaccination HCP Education in Saudi Arabia ($75K), plus a separate Pediatric Pneumococcal Surveillance research call in Saudi Arabia ($400K per project). Novo Nordisk Foundation runs four parallel calls of its own at substantial scale: Infectious Diseases Catalyst Grants (DKK 60M pool, up to DKK 7M collaborative), Non-Diabetic Endocrinology Collaborative Grants (DKK 53M pool, DKK 5-10M per project), Pioneer Innovator Grant Health (DKK 1.1M), and Distinguished Innovator Grant Health (DKK 6.8M). LEO Foundation deploys DKK 2-4M per project for dermatology research excellence. Pfizer’s framing across calls deliberately separates the funding from product promotion, emphasizing measurable practice-relevant change and structural distance between scientific outputs and commercial activity. Novo Nordisk’s “use-inspired” hard filter pushes researchers toward a credible translation pathway from mechanism to deployable tool. The pattern: industry-aligned funders are running structurally independent portfolios at meaningful $ that fund implementation evidence, not promotion. In AI as Operational Capability, Not Speculation, several calls this month explicitly treat AI adoption as a near-term operational question with real evidence and governance requirements, rather than a speculative trend to be watched. Wellcome’s ESIC Hubs frames AI as “the accelerator” for evidence synthesis, asking hubs to translate technical innovation into adoption-ready workflows that can match real-world policy timelines. UNICEF Venture Fund’s new Climate Tech for Children’s Health call funds for-profit startups deploying AI, machine learning, and blockchain in low-resource environments, with a strict requirement that solutions must already have a working prototype with promising pilot results. The Water Research Foundation has launched two simultaneous AI calls treating reproducibility, cybersecurity guardrails, and human-in-the-loop deployments as core design constraints rather than nice-to-haves: one on GenAI and Agentic AI in water utilities ($200K), one on alternatives to water shutoffs that explicitly screens for implementation economics evidence. Nordic Innovation’s quantum technology call (NOK 4.5M) extends the same logic into life science and healthcare, demanding consortium-stage projects mature enough to test with real users. TEF-Health offers €300K in subsidized testing infrastructure for European healthcare AI and robotics SMEs. The pattern: funders are converting AI pilots into playbooks, requiring transfer evidence and risk controls before AI can move from experimentation to sector-wide operational practice. For LMIC-based researchers in infectious disease or evidence synthesis, the three Wellcome calls together represent the deepest concentration of LMIC-led research capital in recent memory — pair the Infectious Disease Clinical Trial Development Award (£200K, deadline May 19) as a strategic pipeline feeder into the larger Infectious Disease Clinical Trial Award (£1-£8M, deadline June 2), since the development award functions explicitly as a track into the larger trial scheme. For Nordic researchers, the four Novo Nordisk Foundation calls plus LEO Foundation and Nordic Innovation Quantum represent ~$30M in regional research capital this cycle, all with deadlines clustered in May-August. For WASH practitioners, the three Water Research Foundation calls together (each up to $200K) are a cluster worth reading across — one on AI deployment, one on shutoff alternatives, one rewarding applied innovation — and the strongest applicants will articulate how their work bridges utility operations to policy-relevant evidence. For US-based clinical researchers and educators, the four Pfizer calls plus the APF Portfolio’s 80+ programs form an unusually accessible recurring pipeline; APF’s prohibition on indirect costs is a meaningful structural feature for early-career applicants whose institutions might otherwise absorb significant overhead. Snapshot of New Opportunities Total Estimated Funding Pool: $100 Million+ USD The grants are organized into three categories: Open Calls: Current grant and opportunities with a deadline. Grants are listed by closing date. 39 open opportunities- 14 new! Rolling Applications: current grant and opportunities with rolling applications (but it’s still best to submit as early as possible). 14 rolling opportunities- 1 new opportunity! Long term planning: Grants that have closed their current rounds, but are expected to open new windows. 4 long term opportunities! A quick tip for returning readers: if you want to jump straight to the newest additions, use CTRL F to search for “New!” and navigate quickly to the latest funding opportunities This post is for paid subscribers. This helps support the time and effort it takes to curate and organize these opportunities. Subscribe To keep this accessible to everyone who needs it, we’re happy to offer pay what you can rates. You can find more details here. Open Calls: Migraine Competitive Grant Program: Migraine and Women’s Health (Quality Improvement and/or Research RFP), Pfizer.*Closing soon!* Pfizer, in collaboration with the American Headache Society, is seeking independent quality improvement and research projects that close persistent gaps in migraine care for women across the United States. The funding logic centers on measurable, practice-relevant change: proposals should generate actionable evidence, tools, or system improvements that can be shared and used widely, not just within a single site. Priority areas span menstrual migraine and screening in women’s health settings, the role of hormonal fluctuations across the lifespan, sex-specific risk factors, comorbidities and quality-of-life burden, and disparities in outcomes by race, ethnicity, and socioeconomic status. The call is structured as a two-step competitive process with an initial Letter of Intent, with the strongest concepts expected to translate scientific insight into implementable improvements in diagnosis, management, and equity. Geographies: United States. Who can apply: U.S.-based organizations (not individuals), including professional schools, healthcare institutions, professional organizations, and other entities focused on healthcare improvement. Funding amount: Up to USD $200,000 total over 2 years; total pool USD $500,000. Targeted Sectors / SDGs: Health; Focus areas: migraine, women’s health, quality improvement, clinical research, menstrual migraine, health disparities. Deadline: LOI: May 5, 2026; Full proposal (by invitation): August 28, 2026. Learn more and apply here. This RFP rewards “shareable impact”: the most competitive submissions will pair rigorous methods with a clear plan for system uptake and dissemination beyond the originating institution. ReSSARC: Strengthening the Health Sector and Food Security in the Central African Republic (AID 013381/01/0) Call for Proposals, Italian Agency for Development Cooperation (AICS). *Closing soon!* AICS is seeking a limited set of high-capacity humanitarian partners to deliver an integrated package that stabilizes essential health services while reducing acute malnutrition and strengthening food security resilience in priority areas of the Central African Republic. The funder’s logic is explicitly nexus-based: proposals should meet urgent, life-saving needs while reinforcing local systems, coordination mechanisms, and community-level capacity so results persist beyond the emergency window. AICS emphasizes inclusion and protection outcomes, expecting gender-sensitive design and explicit measures for groups facing compounded vulnerability, including women, children under five, internally displaced people, and people with disabilities. The call also signals a localization pathway, encouraging stronger collaboration with national NGOs and balanced partnerships, alongside clear coordination with existing cluster and humanitarian actors to minimize duplication and improve coverage. Geographies: Central African Republic (Bangui, Ombella-Mpoko, Ouham, Ouham-Pende, Lim-Pende, Lobaye). Who can apply: Non-profit organizations registered with AICS, plus eligible non-profits without an office in Italy that have a pre-existing collaboration agreement with an AICS-listed organization. Funding amount: Total pool EUR €1,800,000; max EUR €800,000 (single applicant) or EUR €1,000,000 (ATS). Targeted Sectors / SDGs: Health; Focus areas: malnutrition prevention and treatment, maternal and child health, community health services, food security and resilience, localization partnerships Deadline: May 5, 2026. Learn more and apply here. This call is structured to reward partners who can link frontline service delivery to system durability and localization, not just short-term coverage gains. Contracts for Innovation in drug and alcohol addiction healthcare, Innovate UK. *Closing soon!* Innovate UK, on behalf of the Office for Life Sciences Addiction Healthcare Goals program, is procuring R&D to accelerate innovations that can improve treatment outcomes, strengthen recovery, and reduce harm and deaths linked to drug and alcohol addiction. The competition is positioned as a market-facing readiness push: selected projects are expected to advance solutions toward later-stage validation, generate evidence of user acceptability and UK market fit, and map credible routes through regulatory and certification requirements. Innovate UK signals a preference for innovations that can be field-tested in relevant UK settings and progressed to TRL 6 or 7, with practical plans for commercialization after contract completion. This structure favors applicants that can execute most work in-house, co-develop with service providers and people with lived experience, and translate technical progress into deployable tools for addiction healthcare delivery. Geographies: United Kingdom. Who can apply: Single organizations of any size (including EU, EEA, or international) leading delivery, with most work and key deliverables carried out in the UK; subcontractors for specialist skills only. Funding amount: GBP £200,000–1.5 million per project (inclusive of VAT); Total pool: GBP £20 million (across two strands). Targeted Sectors / SDGs: Health; Focus areas: Mental Health, Health Systems Strengthening, Research & Development, Technology Access. Deadline: May 6, 2026 (11:00am). Learn more and apply here. This call uses procurement to pull near-market addiction innovations toward operational proof and adoption pathways in UK services.
New Treatment at UToledo Health Uses Patient’s Blood Cells to Accelerate Healing
A concentrated solution of the patient's own blood platelets is injected to encourage accelerated healing in a specific area of the body.
Record-Setting Retreat of Hektoria Glacier
Scientists relied on satellite data to understand how the Antarctic glacier lost so much ice so rapidly.
Weight loss drug Ozempic linked to lower depression and anxiety risk
GLP-1 drugs like semaglutide—best known for treating diabetes and driving weight loss under the brand names Ozempic and Wegovy—may also deliver a surprising mental health boost. In a massive study tracking nearly 100,000 people over more than a decade, researchers found that these medications were linked to significantly fewer psychiatric hospital visits and sick days.
Fairview residents surprised by proposed behavioral health treatment center
Wasilla-based True North Recovery plans to expand its services to Anchorage using federal grant money held by the municipality.
Health Ministry changes medical cannabis guidelines, passes responsibility to insurance funds
Cannabis may still be considered in severe cases, such as insomnia or acute distress, but only alongside proven treatments like psychotherapy and under close supervision.
Apotex Gets Health Canada Approval for Generic Semaglutide
Apotex receives Health Canada approval for generic semaglutide injection, matching all commercial formats of Novo Nordisk's Ozempic for type 2 diabetes treatmen
‘The reality, for better or worse’: Columbia comp sci students and faculty grapple with AI’s disruption of the field
‘The reality, for better or worse’: Columbia comp sci students and faculty grapple with AI’s disruption of the field ‘The reality, for better or worse’: Columbia comp sci students and faculty grapple with AI’s disruption of the field A field that once seemed like a direct path to stable, lucrative work is becoming less certain under AI, students and faculty told Spectator. By Ria Vasishtha and Arjun Menon May 3, 2026 Shanying Liu / Deputy Illustrations Editor Asia Genawi, SEAS ’29, first encountered artificial intelligence during her sophomore year at her high school in Indiana. Back in 2023, policies on AI varied widely—even within the same district—and some schools had no guidance at all. As Genawi began to see the effects of AI trickle into her classroom, she turned to guidance from her home state’s Department of Education, which she said she found “outdated and inaccessible.” Genawi spent the rest of her high school career dedicated to the issue, including writing a 15-page memo exploring varying AI policies across Indiana schools, which she sent to every Indiana state senator and representative whose contact information she was able to find. She later helped draft a bill that would have required public high schools to establish and share their own AI policies with students in an accessible format. But with so many other bills already awaiting referral, hers never made it to committee. When Genawi arrived at Columbia to study computer science, she found that the gaps she had spent years trying to address in Indiana had followed her there. Many students and professors were also grappling with what AI meant for the field. Across Columbia’s undergraduate schools, computer science has become the most popular major—accounting for around 11 percent of degrees awarded in Columbia College, 32 percent in the School of Engineering and Applied Science, and 12 percent in the School of General Studies in 2024. While the number of computer science majors in SEAS grew from 166 to 173 during the 2024-25 academic year, the total number across the three schools fell around 4.5 percent from 393 to 375, driven by declines at Columbia College and General Studies. At Barnard, it has grown to become the second most popular major as of 2025, up from third the year prior. The number of degrees awarded have grown fivefold since 2016. Faculty members and students in the department told Spectator that the surge in the major’s popularity has been driven in large part by its apparent promise of a secure, well-paid career path. However, they noted that the recent rise of generative AI has compromised the sense of stability that once defined the field, even as interest in technical skills among students persists. According to data from the Federal Reserve Bank of New York in 2024, out of 74 majors tracked, computer science had the fifth highest unemployment rate among majors at 7 percent, while computer engineering had the second highest at 7.8 percent. “Anecdotally, people are moving away from CS as a major,” Daniel Bauer, a senior lecturer in the computer science department, said. “They’re still taking some of our classes, right, because they think they need that, but they’re instead majoring in other things.” Bauer described a field that had shifted from what he called a “nerdy outlier discipline” to one that “everyone needs,” a sign that technical skills have become a baseline expectation across industries with the emergence of AI. “A lot of people thought, ‘Oh, it’s a guaranteed path to a stable income. You get a six-figure job right out of your undergrad,’” Bauer said. Now, companies may see AI as a way to reduce demand for entry-level programmers, especially in what he calls “code monkey jobs,” roles where a large number of employees are “just writing out code nine-to-five.” Chris Murphy, a senior lecturer in the computer science department, described the current moment as the convergence of two forces: the downturn of the job market and generative AI coming onto the scene. “Things kind of started to really pick up in 2014, 16,” he said, recalling the years after the weaker 2010 market. Murphy added that this was also a period where “students were getting more experience outside of class than they were inside of class” through internships, jobs, and side projects. Murphy suggested that the earlier momentum helped make computer science feel like both an academic program and a reliable pathway into work. That feeling is harder to sustain now as the industry reconfigures, which is a shift that students are seeing firsthand. Rebecca Yu, SEAS ’27, said that during a recent internship in Big Tech, she saw that “every single tech company was racing to integrate” large language models. She added that her manager said her intern class was the first to complete their assigned projects, which she attributed to the increased efficiency that comes with AI. Frank Liu, SEAS ’29, said that with AI lowering the barrier to coding, companies now expect everyone to write code. “A lot of companies outright say if you’re not using coding in your job, you might get fired for not being productive enough,” Liu said. Yu similarly expressed that students increasingly have to accept AI being a part of industry workflow, adding that many also “make use of it to maximize their productivity.” Richard Li, CC ’28, described a “franticness” among his peers as the pace of change accelerates. He explained how “some new tool” is released regularly, noting that tools rise and fall in prominence within weeks. He has come to believe that he doesn’t need to “match that speed all the time” and keep up with every development. Li has learned that AI tools allow him to “take a breath” and “get back into the loop much easier than before” when he needs to. While some companies specifically target Columbia when hiring, sending representatives to campus career fairs and recruiting large numbers from Columbia, a computer science degree cannot be treated as a static credential, Yu described. “You can’t just get your degree and stop learning after that. You have to always be learning,” Yu said. “That is something you basically have to expect for your job.” AI has not only affected students’ decisions to major in computer science, but also reshaped how the subject is taught. Across departments, faculty members no longer treat work done outside the classroom as a reliable measure of understanding, shifting instead toward in-person exams, quizzes, and attendance checks. While homework once made up as much as 60 to 70 percent of a student’s grade in computer science classes, Murphy said that breakdown has since flipped, with exams and quizzes now accounting for the majority. “The assumption—especially among pessimists—is that they’re using it to do their homework,” Murphy said. “They take the homework assignment. They put it into generative AI. Out comes the solution. Submit solution. The end.” Murphy said that faculty members ranged in their responses from fully prohibiting AI use to actively teaching students how to effectively work with AI. He said he shifted his approach this year after his teaching assistants called his belief that students weren’t using the technology “naïve,” and now permits students to use AI on assignments. His surveys of students in his introductory classes have told a more complicated story than the one so-called pessimists offer: Around 60 to 70 percent of students who reported using AI said they used it to have concepts explained to them, to clarify assignment instructions, to generate test cases, or to create practice questions. “Those are all ways that you might have had a tutor in the past to do that, and now you have this AI essentially as your tutor,” he said. Bauer has taken a different approach, teaching students how to use AI productively without sacrificing the core principles of the discipline. “People who are trained to actually use AI tools productively, while being in charge of designing the overall project, will be very much in demand in the next couple of years,” he said. Over the past year, a working group of computer science faculty has been redesigning the introductory and intermediate programming sequence to integrate generative AI as both a subject and a tool, representatives from SEAS wrote in a statement to Spectator. The effort is “coordinated” across the department, “not course-by-course,” with a systematic assessment of how AI integration is affecting student outcomes underway to shape the next round of changes. The goal, the department explained, is for students to be able to “read, verify, and reason about code, whether they or a model wrote it.” Tony Dear, senior lecturer in the computer science department, is piloting individualized AI feedback in a discrete mathematics course, while a machine learning course is also testing a Socratic AI dialogue system designed to “guide inquiry rather than supply answers,” the statement reads. Beyond individual courses, SEAS funded seven cross-departmental faculty projects in generative AI this past academic year, spanning biomedical engineering, chemical engineering, industrial engineering, and computer science, according to the statement. This phenomenon extends beyond the computer science department. SEAS’ new AI minor, which it announced in November 2025, reflects the University’s attempt to adapt. The minor is specifically designed for noncomputer science majors and aims to provide “essential AI knowledge” while emphasizing practical and responsible use across disciplines, according to the SEAS website. At the center of the minor is AI in Context, a course taught by a team of faculty from the departments of computer science, applied mathematics, philosophy, music, literature, and the Writing Center, the representatives told Spectator. Bauer described it as targeted at students who want to bring AI into fields like economics or biology, rather than as a path into software engineering itself. At the graduate level, SEAS announced a new Master of Science in artificial intelligence in February, with the inaugural cohort starting in the fall. While recognizing how AI has helped them navigate coursework, students also described its rise as isolating, even among members of the Application Development Initiative, one of Columbia’s largest computer science clubs. “As people start to ask AI for questions that they would normally ask students and members, it starts to isolate people” Li said. Alexa Kafka, BC ’27, echoed Li’s sentiment, pointing out that computer science has always been a collaborative discipline with code reviews and pull requests, even as AI makes independent work easier. Despite this, Kafka noted that she hasn’t been to office hours “in at least a year.” Bauer added that faculty are exploring long-term solutions to the assessment problem. “One of the things that we’re trying to do at the department or school level is to maybe move towards computerized testing facilities,” Bauer said, referring to ideas in the department to revitalize computer labs as an alternative to pen-and-paper exams. “We have to accept that this is the reality, for better or worse.” But more exams, students say, does not mean better learning, nor does it reflect how computer science is actually done. “Code is so variable and can be approached in so many directions, there’s never just going to be one correct answer. There can be multiple optimal solutions,” Kafka said. Students also expressed concern that the shift toward exam-heavy grading pulls focus away from the applied, project-based work that better reflects both discipline and industry expectations. ADI has tried to respond more quickly than the curriculum can. Through a vibe coding workshop this past semester, club members said they wanted to help students understand not just that AI exists, but how to use it deliberately. “Vibe coding” refers to the practice of prompting AI to write code for a task or project, and has become widespread enough that ADI felt the gap in formal instruction was worth addressing, according to Sophia Huang, BC ’29. The workshop introduced students to the concept of context engineering, which Shaina Sahu, SEAS ’27, described as not just writing a prompt, but optimizing “the rest of the relevant information that you would feed into the model.” Without that, students said that AI-generated code can fail at scale or introduce difficult-to-detect bugs. Genawi said the shift toward AI has changed what it means to be good at computer science. “I think the shift has kind of gone towards what can you create and what can you do, instead of, what do you know,” she said. Indeed, during ADI DevFest, its annual hackathon, Li said more teams are trying to complete their projects than in years past. While sign-ups have historically outpaced submissions, Li said this is beginning to change because teams “have a tool that completes the vision for them.” While many students see AI as an equalizer that lowers the barrier to entry for coding and technical work, Murphy said it also creates new equity concerns inside the classroom around who can afford stronger tools and who already knows how to use them. “The equity issues I worry about are students who have access to paid versions of things versus free versions of things,” he said. Although popular AI models like ChatGPT and Claude have free versions available, both have paid models that can reach over $100 per month, which output different qualities of code. Murphy also pointed to differences in prior exposure to AI literacy itself. “Students who go to high schools or K-12 education, where they’re taught AI literacy, prompt engineering, context engineering, they understand how to do this, as opposed to students who go to schools who don’t teach that,” he said. “Then they come in, and then they’re somehow expected to know how to use these tools.” For Genawi, those disparities begin long before students arrive on campus. “It’s very interesting to consider how lucky you were geographically,” she said. “To be born where you were is influencing your ability to get access to these spaces.” Students like Yu, though broadly apprehensive about the future of computer science, are not without hope. “I’m optimistic, because I think if you’re truly passionate about CS, there will definitely be a place in the field to do something you want to do,” she said. Senior Staff Writer Ria Vasishtha can be contacted at ria.vasishtha@columbiaspectator.com. Follow Spectator on X @ColumbiaSpec. Staff Writer Arjun Menon can be contacted at arjun.menon@columbiaspectator.com. Follow Spectator on X @ColumbiaSpec. Want to keep up with breaking news? Subscribe to our email newsletter and like Spectator on Facebook. Produced with Spectate by Emily Ta
New in-game animation for Ingrid shown off by Street Fighter 6 Director
Ingrid is the final character coming to Season 3 of Street Fighter 6. She'll become available for players to use starting on May 28, 2026.The Street Fighter 6 developers recently treated fans to Ingrid's pre-fight animations. Evidently ...
3 Medical Routines That Older People May Not Need
Some screenings and treatments no longer make sense for patients as they age. Researchers have just added a few more to the list.
Grand Forks Public Health advises against using kratom products without medical oversight
Kratom is a plant, native to Southeast Asia, that is used in products that people ingest to self-treat pain, anxiety, depression and opioid withdrawal. The products are not FDA approved.
First malaria drug for babies is approved in ‘major public health milestone’
WHO prequalification of Coartem Baby means newborns can be safely treated rather than using medication for older children
Scientists sound alarm as dangerous amoebas spread globally
Free-living amoebae are emerging as a global health concern, fueled by warming temperatures and outdated water systems. While many are harmless, some can cause deadly infections and even protect other dangerous microbes. Their ability to survive heat and disinfectants makes them especially hard to control. Scientists say improved surveillance and water treatment are urgently needed.
Surgery still outperforms GLP-1 drugs in terms of heart health
Both treatment options are effective, but metabolic and bariatric surgery was linked to more significant cardiovascular risk reductions than GLP-1 medications.
Seattle’s mayor waves goodbye to prosperity
Starbucks retreats from Seattle after the socialist mayor urged a boycott.
The Next Alzheimer’s Breakthrough Will Take More Than Just Science
At WIRED Health, pioneering Alzheimer's researcher John Hardy outlined the stakes—and next steps—of where treatment is headed next.
I'm trying to delay menopause to 60. Here's how I'm doing it
Kayla Barnes-Lentz is using diet, lifestyle changes, and experimental treatments to slow ovarian aging and push menopause as late as possible.
From Sick Care to Whole Health: 5 Forces Reshaping the Future of Healthcare
/PRNewswire/ -- Healthcare is entering a new era—one that moves beyond treating disease to addressing the full complexity of human health and well-being....
AI Can Spot Pancreatic Cancer Years Before Diagnosis, Study Finds
Catching this deadly disease while it's treatable can save lives.
New treatment cuts bad cholesterol by nearly 50% without statins
A new breakthrough could change how high cholesterol is treated, offering a powerful alternative to traditional drugs. Researchers have developed tiny DNA-based molecules that shut down PCSK9—a key protein that keeps “bad” LDL cholesterol circulating in the blood. By blocking this protein, cells can absorb more cholesterol instead of letting it build up in arteries, dramatically lowering levels linked to heart disease.
Medicare, Medicaid privileges officially end at Laurel Ridge Treatment Center
As of Thursday morning, Laurel Ridge officially was cut off from Medicare and Medicaid benefits. Patients using those forms of coverage will now have to seek treatment elsewhere.
Triumph Over Tremors
UCLA Health and the Be Still Foundation host the Triumph Over Tremors Pickleball Tournament Series May 16th — uniting communities nationwide to support those with Essential Tremor and Parkinson’s, with proceeds funding awareness, education, support, and access to life-changing treatments.